Study revealed link between long-term particulate matter exposure and apnea hypopnea index
WEDNESDAY, Oct. 8, 2025 (HealthDay News) — Higher exposure to long-term air pollution may worsen symptoms of sleep apnea, according to a study presented at the annual congress of the European Respiratory Society, held from Sept. 27 to Oct. 1 in Amsterdam.
Martino Pengo, M.D., Ph.D., from the University of Milano-Bicocca in Italy, and colleagues investigated the association between long-term exposure to particulate matter (PM10) and obstructive sleep apnea (OSA) severity in 25 different European cities. The analysis included data from 19,325 patients integrated with data of PM10 concentrations extracted from the Copernicus Atmosphere Monitoring Service.
The researchers found that a one-unit increase in long-term PM10 exposure was associated with a 0.41 increase in the apnea hypopnea index. There was no association for peripheral oxygen saturation or the percentage of time during sleep that a person”s blood oxygen saturation drops below 90 percent. There were significant regional differences in both intensity and impact of association.
“Even after we took account for other factors that we know have an effect on OSA, we still found an average increase in the number of respiratory events per hour of sleep of 0.41 for every one-unit increase in PM10,” Pengo said in a statement. “This effect may seem small for an individual, but across entire populations it can shift many people into higher-severity categories, making it meaningful from a public health perspective.”
Air Pollution Does Not Impair Benefits of Walking in Reducing COPD Exacerbation Rate
Nearly 3 in 4 Older Adults Express Interest in Vaccine to Prevent Dementia
Air Pollution Tied to Higher Risk for Suicide
People With Autism Have Shorter Life Expectancy
Autism Spectrum Disorder Diagnoses Increased for Females Since 2020
Onset of Mortality, Morbidity Delayed for Offspring of Centenarians
Acute Myeloid Leukemia Increasingly Impacting Older Adults Globally
December 2024 to 2025 Saw Significant Increase in Leucovorin Dispensing